ARS Investment Partners’s Exact Sciences EXAS Stock Holding History

ARS Investment Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,555	Closed	-$205K	–	142
2021 Q1	$205K	Sell	1,555 -3,825	-71%	-$524K	0.02%	130
2020 Q4	$713K	Sell	5,380 -1,690	-24%	-$204K	0.09%	74
2020 Q3	$721K	Sell	7,070 -173,321	-96%	-$15M	0.11%	69
2020 Q2	$15.7M	Sell	180,391 -2,541	-1%	-$203K	2.95%	11
2020 Q1	$10.6M	Sell	182,932 -31,472	-15%	-$2.56M	2.56%	13
2019 Q4	$19.8M	Buy	214,404 +103,285	+93%	+$9.08M	3.33%	9
2019 Q3	$10M	Buy	111,119 +90,144	+430%	+$10.3M	1.8%	23
2019 Q2	$2.48M	Buy	20,975 +10,100	+93%	+$1.02M	0.42%	53
2019 Q1	$942K	Buy	+10,875	New	+$926K	0.17%	76

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ARS Investment Partners's EXAS Position: Q2 2021 in Review

ARS Investment Partners sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 1,555 shares — an estimated $205K sold.

ARS Investment Partners first reported a position in EXAS in Q1 2019 and held it in 9 quarters. The position peaked at $19.8M in Q4 2019. 622 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

ARS Investment Partners reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
ARS Investment Partners sold 1,555 Exact Sciences shares in Q2 2021, an estimated $205K.
ARS Investment Partners first reported a position in Exact Sciences in Q1 2019 and held it in 9 quarters.
ARS Investment Partners's Exact Sciences position peaked at $19.8M in Q4 2019.
622 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on ARS Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.